Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab + Glucocorticoids for Chronic GvHD
NCT01680965Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Nov 2012
- Primary completion
- Aug 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic graft-versus-host disease (cGVHD), sponsored by Moffitt Cancer Center. Started Nov 2012; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01680965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680965.